Literature DB >> 17924360

The analysis of continuous outcomes in multi-centre trials with small centre sizes.

Ruth M Pickering1, Mark Weatherall.   

Abstract

The standard analysis of clinical trials stratified by centre is to include centres as fixed effects, but if many centres contribute small numbers of patients, this approach results in a loss of power. Assuming no treatment by centre interaction, we used simulation to examine power and coverage of confidence intervals from three approaches to the analysis of continuous outcome in multi-centre trials: ignoring centres, including centres as fixed effects, and including them as random effects. The simulation incorporated eight sizes of centre effects; randomization in blocks of size 2 or 4; and two sample sizes, namely 100 and 200 patients per treatment arm in a parallel groups design. All simulated data sets included many centres with few subjects. The three different approaches were unbiased and had similar coverage. Fixed effects analysis was less powerful, particularly when centre effects were small. Incorporating block randomization with larger block size increased non-orthogonality in the design, contributing to loss of power. Where centre effects are small and recruitment in many centres is low, the approaches of ignoring centres or incorporating them as random effects have better performance than the traditional fixed effects analysis. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 17924360     DOI: 10.1002/sim.3068

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  9 in total

Review 1.  Many multicenter trials had few events per center, requiring analysis via random-effects models or GEEs.

Authors:  Brennan C Kahan; Michael O Harhay
Journal:  J Clin Epidemiol       Date:  2015-04-02       Impact factor: 6.437

2.  Surgical fixation compared with cast immobilisation for adults with a bicortical fracture of the scaphoid waist: the SWIFFT RCT.

Authors:  Joseph Dias; Stephen Brealey; Liz Cook; Caroline Fairhurst; Sebastian Hinde; Paul Leighton; Surabhi Choudhary; Matthew Costa; Catherine Hewitt; Stephen Hodgson; Laura Jefferson; Kanagaratnam Jeyapalan; Ada Keding; Matthew Northgraves; Jared Palmer; Amar Rangan; Gerry Richardson; Nicholas Taub; Garry Tew; John Thompson; David Torgerson
Journal:  Health Technol Assess       Date:  2020-10       Impact factor: 4.014

3.  Update on the transfusion in gastrointestinal bleeding (TRIGGER) trial: statistical analysis plan for a cluster-randomised feasibility trial.

Authors:  Brennan C Kahan; Vipul Jairath; Michael F Murphy; Caroline J Doré
Journal:  Trials       Date:  2013-07-10       Impact factor: 2.279

4.  Comparing methods to estimate treatment effects on a continuous outcome in multicentre randomized controlled trials: a simulation study.

Authors:  Rong Chu; Lehana Thabane; Jinhui Ma; Anne Holbrook; Eleanor Pullenayegum; Philip James Devereaux
Journal:  BMC Med Res Methodol       Date:  2011-02-21       Impact factor: 4.615

5.  Sample size calculation in multi-centre clinical trials.

Authors:  Markus Harden; Tim Friede
Journal:  BMC Med Res Methodol       Date:  2018-11-29       Impact factor: 4.615

6.  Design and analysis of stratified clinical trials in the presence of bias.

Authors:  Ralf-Dieter Hilgers; Martin Manolov; Nicole Heussen; William F Rosenberger
Journal:  Stat Methods Med Res       Date:  2019-05-10       Impact factor: 3.021

7.  Adjusting for multiple prognostic factors in the analysis of randomised trials.

Authors:  Brennan C Kahan; Tim P Morris
Journal:  BMC Med Res Methodol       Date:  2013-07-31       Impact factor: 4.615

8.  Accounting for centre-effects in multicentre trials with a binary outcome - when, why, and how?

Authors:  Brennan C Kahan
Journal:  BMC Med Res Methodol       Date:  2014-02-10       Impact factor: 4.615

9.  A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trial.

Authors:  Suzie Cro; Prakash Patel; Jonathan Barker; David A Burden; Christopher E M Griffiths; Helen J Lachmann; Nick J Reynolds; Richard B Warren; Francesca Capon; Catherine Smith; Victoria Cornelius
Journal:  Trials       Date:  2020-02-10       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.